Lactobacillus rhamnosus JY02 Ameliorates Sarcopenia by Anti-Atrophic Effects in a Dexamethasone-Induced Cellular and Murine Model

키워드

참고문헌 (70)

1. Ali S, "Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review", Gerontology, 60, pp.294~305 (2014)
2. Wiedmer P, "Sarcopenia - molecular mechanisms and open questions", Ageing Res. Rev, 65, pp.101200~ (2021)
3. Xie WQ, "Mouse models of sarcopenia: classification and evaluation", J. Cachexia Sarcopenia Muscle, 12, pp.538~554 (2021)
4. Giron M, "Gut microbes and muscle function: can probiotics make our muscles stronger?", J. Cachexia Sarcopenia Muscle, 13, pp.1460~1476 (2022)
5. Jimenez-Gutierrez GE, "Molecular mechanisms of inflammation in sarcopenia: Diagnosis and therapeutic update", Cells, 11, pp.2359~ (2022)
6. Nardone OM, "Inflammatory bowel diseases and sarcopenia: The role of inflammation and gut microbiota in the development of muscle failure", Front. Immunol, 12, pp.694217~ (2021)
7. Li HY, "Effects and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics on metabolic diseases targeting gut microbiota: A narrative review", Nutrients, 13, pp.3211~ (2021)
8. Strasser B, "The effects of lifestyle and diet on gut microbiota composition, inflammation and muscle performance in our aging society", Nutrients, 13, pp.2045~ (2021)
9. van Krimpen SJ, "The effects of Pro-, Pre-, and synbiotics on muscle wasting, a systematic review-gut permeability as potential treatment target", Nutrients, 13, pp.1115~ (2021)
10. de Vrese M, "Probiotics, prebiotics, and synbiotics", Adv. Biochem. Eng. Biotechnol, 111, pp.1~66 (2008)
11. Jäger R, "Probiotic administration increases amino acid absorption from plant protein: a placebo-controlled, randomized, double-blind, multicenter, crossover study", Probiotics Antimicrob. Proteins, 12, pp.1330~1339 (2020)
12. Gamallat Y, "Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model", Biomed. Pharmacother, 83, pp.536~541 (2016)
13. Azad MAK, "Probiotic species in the modulation of gut microbiota: an overview", BioMed Res. Int, 2018, pp.9478630~ (2018)
14. Pagnini C, "Mucosal adhesion and anti-inflammatory effects of Lactobacillus rhamnosus GG in the human colonic mucosa: A proof-of-concept study", World J. Gastroenterol, 24, pp.4652~4662 (2018)
15. Slover CM, "Lactobacillus: a review", Clin. Microbiol. Newslett, 30, pp.23~27 (2008)
16. Li B, "Lactobacillus helveticus KLDS1. 8701 alleviates d-galactose-induced aging by regulating Nrf-2 and gut microbiota in mice", 9, pp.6586~6598 (2018)
17. Lee CC, "Lactobacillus plantarum TWK10 attenuates aging-associated muscle weakness, bone loss, and cognitive impairment by modulating the gut microbiome in mice", Front. Nutr, 8, pp.708096~ (2021)
18. 김선균, "Role of Probiotics in Human Gut Microbiome-Associated Diseases", Journal of Microbiology and Biotechnology, 29(9), pp.1335~1340 (2019), 한국미생물·생명공학회[DOI]
19. Markowiak P, "Effects of probiotics, prebiotics, and synbiotics on human health", Nutrients, 9, pp.1021~ (2017)
20. Prokopidis K, "Impact of probiotics on muscle mass, muscle strength, and lean body mass: a systematic review and meta-analysis Jof randomized controlled trials", J. Cachexia Sarcopenia Muscle, 14, pp.30~44 (2022)
21. Lee K, "Lactobacillus plantarum HY7715 ameliorates sarcopenia by improving skeletal muscle mass and function in aged Balb", c mice, 2021, pp.22, 10023~
22. Chen LH, "Probiotic supplementation attenuates age-related sarcopenia via the gut-muscle axis in SAMP8 mice", J. Cachexia Sarcopenia Muscle, 13, pp.515~531 (2022)
23. Bindels LB, "Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model", PLoS One, 7, pp.e37971~ (2012)
24. Mehta J, "Role of dexamethasone and methylprednisolone corticosteroids in Coronavirus disease 2019 hospitalized patients: a review", Front. Microbiol, 13, pp.813358~ (2022)
25. Noreen S, "Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19pandemic", Eur. J. Pharmacol, 894, pp.173854~ (2021)
26. Jiang R, "Panax ginseng total protein facilitates recovery from dexamethasoneinduced muscle atrophy through the activation of glucose consumption in C2C12 myotubes", BioMed Res. Int, 2019, pp.3719643~ (2019)
27. Jia H, "Laurel attenuates dexamethasone-induced skeletal muscle atrophy in vitro and in a rat model", Nutrients, 14, pp.2029~ (2022)
28. Baehr LM, "Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids", J. Physiol, 589, pp.4759~4776 (2011)
29. Seo E, "Psoralea corylifolia L. seed extract attenuates dexamethasone-induced muscle atrophy in mice by inhibition of oxidative stress and inflammation", J. Ethnopharmacol, 296, pp.115490~ (2022)
30. Wang BYH, "Is dexamethasone-induced muscle atrophy an alternative model for naturally aged sarcopenia model?", J. Orthop. Translat, 39, pp.12~20 (2023)
31. Otsuka Y, "Quercetin glycosides prevent dexamethasone-induced muscle atrophy in mice", Biochem. Biophys. Rep, 18, pp.100618~ (2019)
32. Massaccesi L, "Dexamethasone-induced skeletal muscle atrophy increases O-GlcNAcylation in C2C12 cells", J. Cell Biochem, 117, pp.1833~1842 (2016)
33. Ticinesi A, "Aging gut microbiota at the cross-road between nutrition, physical frailty, and sarcopenia: is there a gut-muscle axis?", Nutrients, 9, pp.1303~ (2017)
34. Przewłócka K, "Gut-muscle axis exists and may affect skeletal muscle adaptation to training", Nutrients, 12, pp.1451~ (2020)
35. Chen LH, "Probiotic supplementation attenuates age-related sarcopenia via the gut–muscle axis in SAMP8 mice", J. Cachexia Sarcopenia Muscle, 13, pp.515~531 (2022)
36. Markowiak-Kopeć P, "The Effect of Probiotics on the production of short-chain fatty acids by human intestinal microbiome", Nutrients, 12, pp.1107~ (2020)
37. Zhao J, "A narrative review of gut-muscle axis and sarcopenia: the potential role of gut microbiota", Int. J. Gen. Med, 14, pp.1263~1273 (2021)
38. Gou HZ, "How do intestinal probiotics restore the intestinal barrier?", Front. Microbiol, 13, pp.929346~ (2022)
39. Liu Q, "Surface components and metabolites of probiotics for regulation of intestinal epithelial barrier", Microb. Cell Fact, 19, pp.23~ (2020)
40. Indira M, "Bioactive molecules of probiotic bacteria and their mechanism of action: a review", 3 Biotech, 9, pp.306~ (2019)
41. Park YS, "Quantitative analysis of myosin heavy chain (MHC) mRNA expression in thyropharyngeus muscle and cricopharyngeus muscle in rats", Korean J. Otorhinolaryngol-Head Neck Surg, 43, pp.300~305 (2000)
42. Konopka AR, "Myosin heavy chain plasticity in aging skeletal muscle with aerobic exercise training", J. Gerontol. Series A, 66A, pp.835~841 (2011)
43. Chen L, "Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt", mTOR, Oncol. Rep, pp.2019, 42[DOI]
44. Wijaya YT, "Amelioration of muscle wasting by gintonin in cancer cachexia", Neoplasia (New York, N.Y.), 23, pp.1307~1317 (2021)
45. Parry T, "Muscle-specific ubiquitin ligase MuRF1 regulates myocardial autophagic flux in vivo", 29, pp.148~ (2015)
46. Kitajima Y, "The ubiquitin–proteasome system in regulation of the skeletal muscle homeostasis and atrophy: from basic science to disorders", J. Physiol. Sci, 70, pp.40~ (2020)
47. Bindels LB, "Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model", PLoS One, 7, pp.e37971~ (2012)
48. Bodine SC, "Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx", atrogin-1, 2014, pp.307, E469~E484
49. Gumucio JP, "Atrogin-1, MuRF-1, and sarcopenia", Endocrine, 43, pp.12~21 (2013)
50. 송영준, "Setdb1 Is Required for Myogenic Differentiation of C2C12 Myoblast Cells via Maintenance of MyoD Expression", Molecules and Cells, 38(4), pp.362~372 (2015), 한국분자세포생물학회
51. Lin M, "Alpha mangostin promotes myogenic differentiation of C2C12 mouse myoblast cells", Biochem. Biophys. Res. Commun, 528, pp.193~198 (2020)
52. Liu XH, "Nandrolone-induced nuclear accumulation of MyoD protein is mediated by Numb, a Notch inhibitor, in C2C12 myoblasts", Physiol. Rep, 6, pp.e13520~ (2018)
53. Luo W, "Myomaker, regulated by MYOD, MYOG and miR-140-3p, promotes chicken myoblast fusion", Int. J. Mol. Sci, 16, pp.26186~26201 (2015)
54. Hong Y, "Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy", J. Cachexia Sarcopenia Muscle, 10, pp.903~918 (2019)
55. Lee MC, "Effectiveness of human-origin Lactobacillus plantarum PL-02 in improving muscle mass, exercise performance and anti-fatigue", 11, pp.19469~ (2021)
56. Chen L, "Probiotic Lactobacillus rhamnosus GG reduces mortality of septic mice by modulating gut microbiota composition and metabolic profiles", 78, pp.110863~ (2020)
57. Pomeroy E, "Relationship between body mass, lean mass, fat mass, and limb bone cross-sectional geometry: implications for estimating body mass and physique from the skeleton", Am. J. Phys. Anthr, 166, pp.56~69 (2018)
58. Klover P, "Skeletal muscle growth and fiber composition in mice are regulated through the transcription factors STAT5a", b: linking growth hormone to the androgen receptor, 2009, pp.23, 3140~3148
59. Kim S, "Curcuma longa L. Water extract improves dexamethasone-induced sarcopenia by modulating the muscle-related gene and oxidative stress in mice", Antioxidants, 10, pp.1000~ (2021)
60. Sang Yoon Lee, "Handgrip Strength: An Irreplaceable Indicator of Muscle Function", Annals of Rehabilitation Medicine, 45(3), pp.167~169 (2021), 대한재활의학회[DOI]
61. Savary I, "Effect of glucocorticoid excess on skeletal muscle and heart protein synthesis in adult and old rats", Br. J. Nutr, 79, pp.297~304 (1998)
62. Wells L, "Myosin heavy chain isoforms regulate muscle function but not myofibril assembly", Embo J, 15, pp.4454~4459 (1996)
63. Lee H, "Chrysanthemum zawadskil herbich attenuates dexamethasoneinduced muscle atrophy through the regulation of proteostasis and mitochondrial function", Biomed. Pharmacother, 136, pp.111226~ (2021)
64. Hata J, "Noninvasive technique to evaluate the muscle fiber characteristics using q-space imaging", PLoS One, 14, pp.e0214805~ (2019)
65. Ramón Ríos, "Myostatin is an inhibitor of myogenic differentiation", Am. J. Physiol. Cell Physiol, 282, pp.C993~C999 (2002)
66. White TA, "Myostatin and Sarcopenia: opportunities and challenges - a mini-review", Gerontology, 60, pp.289~293 (2014)
67. Dong Y, "Myostatin suppression of akirin1 mediates glucocorticoid-induced satellite cell dysfunction", PLoS One, 8, pp.e58554~ (2013)
68. Pedersen M, "Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes", Mech. Ageing. Dev, 124, pp.495~502 (2003)
69. Rong YD, "Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10", BMC Geriatr, 18, pp.308~ (2018)
70. Visser M, "Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study", J. Gerontol. A Biol. Sci. Med. Sci, 57, pp.M326~M332 (2002)

관련 논문AI추천